Antioxidant Therapy in Nonalcoholic Steatohepatitis

Said A. Al‐Busafi(Royal Victoria Regional Health Centre), Marc Deschênes(Royal Victoria Regional Health Centre), Peter Ghali(Royal Victoria Regional Health Centre), Mamatha Bhat(University Health Network), Philip Wong(University of California, Santa Barbara)
Hepatitis Research and Treatment
November 22, 2012
10.1155/2012/947575
Cited by 61

Related Papers

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
|Hepatology|2014|2k
Global burden of metabolic diseases, 1990–2021
|Metabolism|2024|294
Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021
|EClinicalMedicine|2024|188
Chylous Ascites: Evaluation and Management
|ISRN Hepatology|2014|171
Management of Chronic Hepatitis C: Consensus Guidelines
|Canadian Journal of Gastroenterology|2007|141